Sequenom Inc (NASDAQ:SQNM)
| 4.08 Data as of May 23 |  +0.17 / +4.35%Today’s Change | 2.65 Today|||52-Week Range 5.36 | -13.38% Year-to-Date |
Latest SQNM News | Press Releases
| Not Your Typical Set Up May 22 / StockTwits | Sequenom Meets on the Top Line, Misses Where it Counts May 10 / MotleyFool.com |
Today’s Trading
| Previous close | 3.91 |
| Today’s open | 3.90 |
| Day’s range | -- - -- |
| Volume | 4,146,659 |
| Average volume (3 months) | 2,770,639 |
| Market cap | $469.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +25.46% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +60.44% |
| P/E ratio | NM |
| Price/Sales | 5.97 |
| Price/Book | 9.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CSIICardiovascular Syste... | +1.28 | +7.22% |
| ATRSAntares Pharma Inc | +0.09 | +2.27% |
| ATRIAtrion Corp | +0.37 | +0.18% |
| BABYNatus Medical Inc | -0.08 | -0.57% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $89.7M |
| Annual profit (last year) | -$117.0M |
| Net profit margin | -130.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Harry F. Hixson, Jr., PhD |
President & Chief Operating Officer William J. Welch, MBA |
Corporate headquarters San Diego, California |
Forecasts
